Minnelide alters CAFs’ activation and proliferation by inhibiting the TGF-β and retinoic acid receptors/retinoid X receptors’ pathways and induces tumor apoptosis by inhibiting the NF-κB pathway [109]. The gene discussed is TGFB1; the disease is neoplasm.